Matthew Winton's Net Worth
$5.26 Thousand
Who is Matthew Winton?
Matthew Winton does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Inozyme Pharma, Inc..
SEC CIK
Matthew Winton's CIK is 0001971400
Past Insider Trading and Trends
2024 was Matthew Winton's most active year for acquiring shares with 2 total transactions. Matthew Winton's most active month to acquire stocks was the month of February. 2024 saw Matthew Winton paying a total of $10,616.04 for 178,188 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
COOMatthew Winton owns 3,188 units of Common Stock which is worth $15,876.24. In the year 2023 Matthew Winton acquired a total of 3,188 shares in Inozyme Pharma, Inc. at a cost of $10,616.04.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.19K |
$3.33 | $10,616.04 | 3.19K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||